Sjs Investment Consulting Inc. Astrazeneca PLC Transaction History
Sjs Investment Consulting Inc.
- $647 Million
- Q3 2025
A detailed history of Sjs Investment Consulting Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 8 shares of AZN stock, worth $656. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8
Previous 8
-0.0%
Holding current value
$656
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,453Shares Held
490MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.26 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.38 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.82 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.58 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.56 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $254B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...